No products in the basket.
SET introduces “VENTURE19” DR linked to Singapore’s medical tech stocks
DR “VENTURE19” will start trading on the stock market from February 28, 2024. This is part of the collaboration project “Thailand-Singapore DR Linkage” between the Thai and Singapore stock markets.
The Stock Exchange of Thailand has introduced “VENTURE19,” a Depositary Receipt (DR) representing shares of Venture Corporation Limited, a technology development company in the medical industry in Singapore. The trading of VENTURE19 on the stock market began on February 28th by Yuanta Securities.
DR “VENTURE19” refers to common stock of Venture Corporation Limited, a leading technology company in Singapore, particularly in the medical industry, developing laboratory instruments, genetic testing devices, health products, and semiconductor components for robotics and IoT devices.
DR “VENTURE19” will start trading on the stock market from February 28, 2024. This is part of the collaboration project “Thailand-Singapore DR Linkage” between the Thai and Singapore stock markets.
DR is an instrument in which investors have the opportunity to receive benefits similar to holding foreign securities. Investors can trade through their brokerage account with baht. Those interested in studying the details of DR “VENTURE19” can visit the SEC website. www.sec.or.th or the securities issuing company is Yuanta Securities (Thailand) Company Limited www.yuanta.co.th Or learn more about DR products at www.setinvestnow.com/th/dr
Discover more from Thailand Business News
Subscribe to get the latest posts sent to your email.
